刘宏艳, 邹霜梅, 应建明, 吕 宁. 胃肠道外原发MALT淋巴瘤临床病理特征与预后分析[J]. 中国肿瘤临床, 2011, 38(20): 1254-1257. DOI: 10.3969/j.issn.1000-8179.2011.20.005
引用本文: 刘宏艳, 邹霜梅, 应建明, 吕 宁. 胃肠道外原发MALT淋巴瘤临床病理特征与预后分析[J]. 中国肿瘤临床, 2011, 38(20): 1254-1257. DOI: 10.3969/j.issn.1000-8179.2011.20.005
Hongyan LIU, Shuangmei ZOU, Jianming YING, Ning LV. Clinicopathologic Characteristics and Prognostic Analysis of Extragastrointestinal Primary Mucosa-associated Lymphoid Tissue Lymphoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 38(20): 1254-1257. DOI: 10.3969/j.issn.1000-8179.2011.20.005
Citation: Hongyan LIU, Shuangmei ZOU, Jianming YING, Ning LV. Clinicopathologic Characteristics and Prognostic Analysis of Extragastrointestinal Primary Mucosa-associated Lymphoid Tissue Lymphoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 38(20): 1254-1257. DOI: 10.3969/j.issn.1000-8179.2011.20.005

胃肠道外原发MALT淋巴瘤临床病理特征与预后分析

Clinicopathologic Characteristics and Prognostic Analysis of Extragastrointestinal Primary Mucosa-associated Lymphoid Tissue Lymphoma

  • 摘要: 观察分析胃肠道外原发黏膜相关淋巴组织结外边缘区B细胞淋巴瘤(extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue,MALT淋巴瘤)的预后相关因素。方法:收集近10年具有完整临床病理资料的胃肠道外原发MALT淋巴瘤29例,肺11例,甲状腺7例,腮腺4例,睾丸2例,乳腺1例,眼附属器1例,扁桃体1例,肝脏1例,舌根1例,随访1~101个月(26例随访>12个月);分析比较不同年龄、发病部位、组织学特征、临床分期等临床病理特点以及治疗方案与生存率的关系。结果:1)29例MALT淋巴瘤中位发病年龄55岁(29~80岁),男女之比为1:3,首发症状多为局部肿块;9例(31%)为乙肝病毒(HBV)携带者,HBV感染可能与MALT淋巴瘤的发病机制有一定相关性(P<0.05)。2)组织学上,27例(93.1%)具有MALT淋巴瘤的典型组织学形态特征和免疫表型特征,4例伴有浆细胞样分化,10例伴大细胞转化;3例行IGH/IGK基因重排检测的结果为B细胞受体基因克隆性重排;3)ⅠE期、ⅡE期、ⅣE期的5年生存率分别为92%、100%和69%,ⅠE期和ⅡE期的生存率高于ⅣE期(P<0.05)。不同的原发部位、临床治疗方案以及形态学差异对生存率无影响(P>0.05)。结论:胃肠道外MALT淋巴瘤是一类病因机制尚未明确的惰性淋巴瘤,其预后与临床分期密切相关;HBV感染可能与肿瘤发生相关;不同的原发部位、临床治疗方案以及形态学差异对预后无影响。

     

    Abstract: To review and study the prognostic factors of a panel of extragastrointestinal primary mucosa-associated lymphoid tissue ( MALT ) lymphoma. Methods: Twenty-nine diagnosed cases of extragastrointestinal primary MALT lymphoma with complete clinical information from Cancer Hospital CAMS over a 10-year period were enrolled, and the correlations between their ages, primary site, histological feature, stage, therapeutic measures, and survival rate were retrospectively compared. Results: 1) The ages of the 29 patients ranged from 29-80, with a median of 55; the ratio of male to female was 1:3. The primary symptom was a local mass. Up to 9 ( 31% ) patients were infected with HBV ( P < 0.05 ). 2) Histologically, 27 cases had typical histologic and immunophenotypic characteristics, 14 cases had plasmacyte differentiation with or without a high-grade component. The clonal arrangement of B lymphocyte receptor gene occurred in 3 cases. 3) The total 5-year survival rate of IE, IIE, and IVE based on the Ann Arbor staging system were 92%, 100% and 69%, respectively, and the survival rates of IE and IIE were clearly higher than that of IVE. The differences in primary sites, therapeutic measures, and morphology had no influence on survival rate ( P > 0.05 ). Conclusion: Extragastrointestinal primary MALT lymphoma is an indolent lymphoma with unclear pathogenesis. The prognosis of the lymphoma was closely related to clinical stage. HBV infection may involve the carcinogenesis of the liver. Different primary sites, therapeutic measures, and morphology had no significant effect on the prognosis.

     

/

返回文章
返回